Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Neurologists publish consensus statement on stridor in MSA

Publish date:: October 15, 2019

Key clinical point: A panel of experts has published a consensus statement on the treatment of stridor in MSA.

Major finding: CPAP is a useful symptomatic treatment, while persistent and severe stridor may require tracheostomy.

Study details: A review of the literature on stridor in MSA.

Disclosures: The IRCCS funded the study. One of the authors is a section editor for Neurology, and other authors reported receiving honoraria from various companies such as Novartis, Sanofi, and UCB.

Citation:

Cortelli P et al. Neurology. 2019;93(14):630-9.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Neuromuscular Disorders

Gene-replacement therapy shows promise in X-linked myotubular myopathy,

Ataluren delays disease milestones in patients with nonsense mutation DMD,

Nusinersen provides continued benefits to presymptomatic children with SMA,

Huntington's disease biomarkers appear 24 years before clinical symptoms,

Dermatomyositis without dermatitis correlates with autoantibodies,